CONMED Corporation Announces Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Leerink Partners Cuts Price Target as Conmed (CNMD) Reports 6c EPS Miss
October 22, 2015 8:53 AM EDTLeerink Partners reiterated an Outperform rating on CONMED (NASDAQ: CNMD), and cut the price target to $53.00 (from $60.00), following the company's 3Q15 earnings results. 3Q revenues of $169M were below consensus' $173M estimate. EPS of $0.38 was below $0.44 estimate.
Analyst Richard Newitter commented,... More
Conmed (CNMD) Misses Q3 EPS by 6c, Lowers FY Outlook
October 21, 2015 4:23 PM EDTConmed (NASDAQ: CNMD) reported Q3 EPS of $0.38, $0.06 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $169.2 million versus the consensus estimate of $173.96 million.
Conmed sees FY2015 EPS of $1.65-$1.70, versus prior guidance of $1.82-$1.92 and the consensus of $1.83. Conmed... More
